Wells Bio

Wells Bio is a South Korean biotechnology company specializing in the development and manufacturing of advanced in vitro diagnostic (IVD) solutions. As a subsidiary of Access Bio, the company focuses on molecular diagnostics, rapid diagnostic tests, and biosensors for a wide range of infectious diseases, including COVID-19, malaria, and latent tuberculosis. Wells Bio leverages its proprietary technologies to provide high-sensitivity diagnostic kits and automated platforms for clinical laboratories and point-of-care settings. The company is committed to global health by providing affordable and accurate diagnostic tools to underserved regions.